Nedosiran
Nedosiran is a GalNAc-conjugated double-stranded RNAi therapeutic targeting lactate dehydrogenase (LDH) for primary hyperoxaluria. It is investigated in preclinical and clinical studies for reducing oxalate production, offering a potential treatment for patients with PH and ESRD.
Product Specifications
CAS Number
2266591-83-5
Field of Research
Metabolism Research
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog